A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

Clinical trial NCT02314364 · COMPLETED

Trial details

NCT number: NCT02314364
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic Targetable Oncogenes (EGFR, ALK, ROS1)

Start date: 2014-12-01
Primary completion: 2021-11-10
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.